Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats

World Journal of Gastroenterology

Volumn 7, Issue 1, 2001, Pages 115-119

  Wang, J Y ^a   Zhang, Q S ^a   Guo, J S ^a   Hu, M Y ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGENASE; GLYCYRRHETINIC ACID; MESSENGER RNA; PROCOLLAGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLLAGEN METABOLISM; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE COURSE; DOWN REGULATION; DRUG EFFECT; LIVER FIBROSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; STELLATE CELL;

EID: 0035113172     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v7.i1.115     Document Type: Article

References (53)

1. The chemical morphology of extracellular matrix in experimental rat liver fibrosis resembles that of normal developing connective tissue
2. Fibrogenesis in the liver - Fibrosis, cirrhosis
3. Structure of the extracellular matrix in normal and fibrotic liver: Collagens and glycoproteins
4. Hepatic lipocytes: The principal collagen-producing cells of normal rat liver
5. Formation of extracellular matrix in normal rat liver: Lipocytes as a major source of proteoglycan
6. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rats
7. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
8. Prevention of hepatotoxic responses to chemicals by glycyrrhizin in rats
9. Pharmacokinetics of glycyrrhizin in rats with D-galactosamine-induced hepatic disease
10. A comparison of the antihepatotoxic activity between glycyrrhizin and glycyrrhetinic acid
11. Glycyrrhizic acid inhibits virus growth and inactivates virus particles
12. Effects of glycyrrhizin on hepatitis B surface antigen: A biochemical and morphological study
13. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro
14. RCT of potenlin for treatment of chronic active hepatitis B
15. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis: Double blind trial
16. Intravenous glycyrrhizin for the treatment of chronic hepatitis C: A double-blind, randomized, placebo-controlled phase I/II trial
17. The inhibitory effect of procollagen type I, III mRNA expressions of fibroblasts by glycyrrhizin acid (Potenlini)
18. 4 plus ethanol induced liver injury and hepatic fibrosis in rats
19. Isolation and identification of fat-storing cells from fibrous dog liver with a modified centrifugation
20. Human Pro α1 (I) collagen: cDNA sequence for the C propeptide domain
21. Construction of a human alpha 1 (III) collagen cDNA clone and localization of type III collagen expression in fetal tissues
22. Rat collagenase: Cloning, amino acid sequence comparison, and parathyroid hormone regulation in osteoblastic cells
23. Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo
24. Cellular distribution of transforming growth factor-β 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride - Induced rat liver fibrosis
25. Hepatic stellate cells: A target for the treatment of liver fibrosis
26. Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy
27. Localisation and semiquantitative assessment of hepatic procollagen mRNA in primary biliary cirrhosis
28. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia
29. Significance of collagen III in human and rat liver fibrosis
30. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies
31. 4-plus ethanol-induced liver cirrhosis in rats
32. NF-κB controls expression of inhibitor IκBα: Evidence for an inducible autoregulatory pathway
33. The NF-κB and IκB proteins: New discoveries and insights
34. t: Activation of NF-κB, selective inhibition by antioxidants and integral membrane localization
35. Increased procollagen mRNA levels in carbon-tetrachloride-induced liver fibrosis in rats
36. Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis
37. Collagenolytic activity in experimental cirrhosis of the liver
38. Fibrogenic and collagenolytic activity in carbon-tetrachloride-injured rats: Beneficial effects of zinc administration
39. Dynamic change of the activity of interstitial collagenase in experimental liver fibrosis
40. Serum collagenase activity in patients with chronic liver disease
41. Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
42. Tissue inhibitor of metalloproteinase-1 in the liver of patients with chronic liver disease
43. A one-year trial of lamivudine for chronic hepatitis B. Asia Hepatitis Lamivudine Study Group
44. Dynamic observation on liver fibrosis and cirrhosis of hepatitis B
45. Serologic study on extracellular matrix metabolism in patients with viral liver cirrhosis
46. Therapeutic basis of glycyrrhizin on chronic hepatitis B
47. Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice
48. The long term efficacy of glycyrrhizin in chronic hepatitis C patients
49. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats
50. Experimental and clinical study on inhibition and reversion of liver fibrosis with integrated Chinese and Western medicine
51. Blocking effect of Chinese herbs Yiganxian and PHGF on immuno-damaged hepatic fibrosis in rats
52. 4 induced liver fibrosis in rats
53. Study on the mechanism of matrine on immune liver injury in rats